AI assistant
Sending…
SERA PROGNOSTICS, INC. — Director's Dealing 2021
Jul 15, 2021
34084_dirs_2021-07-14_5aedf665-439a-4d4f-9e9c-805b2a6794a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SERA PROGNOSTICS, INC. (SERA)
CIK: 0001534969
Period of Report: 2021-07-14
Reporting Person: Boniface John J. (Chief Scientific Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.73 | 2022-03-14 | Class A Common Stock (75998) | Direct | |
| Stock Option (right to buy) | $0.73 | 2022-09-11 | Class A Common Stock (5844) | Direct | |
| Stock Option (right to buy) | $0.73 | 2021-12-15 | Class A Common Stock (25012) | Direct | |
| Stock Option (right to buy) | $0.91 | 2024-12-29 | Class A Common Stock (73383) | Direct | |
| Stock Option (right to buy) | $1.98 | 2027-05-18 | Class A Common Stock (112945) | Direct | |
| Stock Option (right to buy) | $1.98 | 2027-06-26 | Class A Common Stock (22042) | Direct | |
| Stock Option (right to buy) | $1.77 | 2030-02-27 | Class A Common Stock (154064) | Direct | |
| Stock Option (right to buy) | $5.32 | 2031-03-08 | Class A Common Stock (77836) | Direct |
Footnotes
F1: These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date and 1/36 of the original grant amount vests in monthly installments for three years following the grant date.
F2: These stock options vest over four years as follows: 1/48 of the original grant amount vests in monthly installments for four years following the grant
date.
More from SERA PROGNOSTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 1
Board/Management Information
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 27
Major Shareholding Notification
2026
Jan 16
Investor Presentation
2026
Jan 8